GenixPharmaceucticals Corporation (GENX) - Total Liabilities

Latest as of April 2026: CA$1.58 Million CAD ≈ $1.14 Million USD

Based on the latest financial reports, GenixPharmaceucticals Corporation (GENX) has total liabilities worth CA$1.58 Million CAD (≈ $1.14 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital position of GenixPharmaceucticals Corporation to evaluate short-term liquidity relative to the company's equity base.

GenixPharmaceucticals Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how GenixPharmaceucticals Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see GENX total asset value.

GenixPharmaceucticals Corporation Competitors by Total Liabilities

The table below lists competitors of GenixPharmaceucticals Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Migo Opportunities Trust PLC LSE:MIGO	UK	GBX11.69 Million
Braemar Plc LSE:BMS	UK	GBX69.89 Million
Nexera Technologies Ltd. NASDAQ:NEXR	USA	$2.88 Million
Arcadia Biosciences Inc NASDAQ:RKDA	USA	$2.41 Million
Rubico Inc. Common Stock NASDAQ:RUBI	USA	$88.27 Million
Nicolas Miguet et Associes SA PA:MLNMA	France	€1.05 Million
Bluejay Diagnostics Inc NASDAQ:BJDX	USA	$1.42 Million
Condmag Brasov RO:COMI	Romania	RON11.76 Million

Liability Composition Analysis (2015–2025)

This chart breaks down GenixPharmaceucticals Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is GenixPharmaceucticals Corporation's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	47.45	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenixPharmaceucticals Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenixPharmaceucticals Corporation (2015–2025)

The table below shows the annual total liabilities of GenixPharmaceucticals Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-10-31	CA$1.47 Million ≈ $1.06 Million	+19.66%
2024-10-31	CA$1.23 Million ≈ $888.86K	-9.71%
2023-10-31	CA$1.36 Million ≈ $984.40K	+29.17%
2022-10-31	CA$1.05 Million ≈ $762.10K	+39.50%
2021-10-31	CA$755.19K ≈ $546.29K	+54.16%
2020-10-31	CA$489.88K ≈ $354.37K	+494.44%
2019-10-31	CA$82.41K ≈ $59.61K	-24.50%
2018-10-31	CA$109.15K ≈ $78.96K	-59.99%
2017-10-31	CA$272.80K ≈ $197.34K	+300.95%
2016-10-31	CA$68.04K ≈ $49.22K	-38.58%
2015-10-31	CA$110.78K ≈ $80.13K	--

About GenixPharmaceucticals Corporation

V:GENX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$885.77K

CA$1.22 Million CAD

Market Cap Rank

#30775 Global

#1598 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.02 - CA$0.04

All Time High

CA$0.29